Back to Search
Start Over
Platelet-cloaked alginate-poly (β-amino ester) a novel platform bioinspired polyelectrolyte nanoparticle for targeted delivery of carboplatin in breast cancer: An in vitro/in vivo study.
- Source :
-
International journal of pharmaceutics [Int J Pharm] 2024 Nov 15; Vol. 665, pp. 124720. Date of Electronic Publication: 2024 Sep 14. - Publication Year :
- 2024
-
Abstract
- Triple-negative breast cancer (TNBC) has poor prognosis. Carboplatin (Crb) is a widely used chemotherapeutic agent, in TNBC but with serious systemic toxicity and poor tumor targeting. Bioinspired drug-loaded platelets (Plt) and Plt-coated nanocarriers evade macrophage phagocytosis by membrane proteins like CD47. The goal of this study was preparation of a novel alginate-poly (β-amino ester) (PβAE) nanoparticles (NPs) for targeted delivery of Crb to TNBC cells by developing and comparison of two bioinspired carriers of Plt membrane (PltM) coated Crb-loaded alginate-poly (β-amino ester) nanoparticles (PltM@Crb-PβAE-ALG NPs) and Plt loaded Crb (Plt@Crb). The NPs were prepared by ionic gelation and subsequently were coated by platelet membrane using ultra-sonication method. The loading efficiency, release profile, and in vitro cytotoxicity of both formulations were evaluated on HUVEC and 4 T1 cells. Additionally, the in vivo tumor targeting, therapeutic efficacy, and organ toxicity of the two formulations were assessed in a murine tumor model. Results showed both Plt@Crb and (PltM@Crb-PβAE-ALG NPs) exhibited high drug loading efficiency, sustained release, enhanced cytotoxicity against 4 T1 cells, and decreased cytotoxicity in normal cells (HUVEC) in vitro. In vivo studies revealed that although both formulations considerably improved tumor inhibition compared to free Crb, but the PltM@Crb-PβAE-ALG NPs demonstrated superior cytotoxicity and therapeutic efficacy, thanks to improved Crb's internalization efficiency, enhanced stability, and controlled release properties.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Subjects :
- Animals
Female
Humans
Cell Line, Tumor
Drug Carriers chemistry
Mice
Polyelectrolytes chemistry
Triple Negative Breast Neoplasms drug therapy
Mice, Inbred BALB C
Cell Survival drug effects
Drug Delivery Systems methods
Breast Neoplasms drug therapy
Breast Neoplasms pathology
Alginates chemistry
Alginates administration & dosage
Blood Platelets drug effects
Blood Platelets metabolism
Carboplatin administration & dosage
Carboplatin chemistry
Nanoparticles chemistry
Nanoparticles administration & dosage
Antineoplastic Agents administration & dosage
Antineoplastic Agents chemistry
Antineoplastic Agents pharmacology
Antineoplastic Agents pharmacokinetics
Drug Liberation
Human Umbilical Vein Endothelial Cells
Polymers chemistry
Subjects
Details
- Language :
- English
- ISSN :
- 1873-3476
- Volume :
- 665
- Database :
- MEDLINE
- Journal :
- International journal of pharmaceutics
- Publication Type :
- Academic Journal
- Accession number :
- 39284421
- Full Text :
- https://doi.org/10.1016/j.ijpharm.2024.124720